IIL to make 10 million doses of Covaxin drug substance from December

By Sumit Blogs -

Indian Immunologicals Limited which has supplied two million doses of drug substance to Bharat Biotech to make COVID-19 vaccine Covaxin, is set to make ten million doses of the drug substance from December, a press release from IIL said on Friday. Lauding the efforts of the PSU for its ability to roll out the vaccine drug substance in record time, Union Minister Parshottam Rupala formally handed over the drug substance to Bharat Biotech, makers of Covaxin, it said.

“To date, IIL has already supplied 2 million doses of the drug substance. It is learned that the drug substance produced by IIL has already been formulated into vaccines by BBIL ( Bharat Biotech) and is ready for use. IIL will produce three million doses a month and from December will increase it to 10 million doses,” the release said.

K Anand Kumar, Managing Director, IIL said, the production and delivery of Covid-19 drug substance in record time is a testament to IIL’s technical expertise, adaptability, state-of-art manufacturing capability, resilience, and above all a commitment to the larger cause in the interest of the nation.

IIL is also developing on a live attenuated COVID-19 vaccine which has many advantages and will be rolled out next year, Kumar said.

The animal studies have been completed and the results are very encouraging. Human trials are also expected to start soon, he added.

Krishna Ella, CMD, Bharat Biotech said it was essential that both competing organisations come together and support each other to a larger cause of national health. “If the Indian companies don’t join hands, then the multinationals will take over the industry,” Ella said. Set up by National Dairy Development Board , Indian Immunologicals Limited is one of the largest producers of vaccines in Asia.

Credits – Source – https://ift.tt/3ENbiAm

The post IIL to make 10 million doses of Covaxin drug substance from December appeared first on Stay in Gurgaon.

Comments

Post a Comment

Popular posts from this blog

Flat sale of flu drugs hints at no unusual rise in infections

By Sumit Blogs -
Image
By Economic Times – Flat sale of flu drugs hints at no unusual rise in infections Industry executives and chemists said the April sales data showed a month-on-month decline of 30-40%. But even though the lockdown is seen to be impacting sales of most drugs, the pattern for medicines for infections and flus is no different.Last Updated: Apr 30, 2020, 11.23 AM ISTAgenciesExperts said the decline in sales was primarily because of the lockdown and other restrictions which forced people to stay indoors. (This story originally appeared in on Apr 30, 2020)NEW DELHI: Sales of anti-infectives (antibiotics and antivirals), respiratory drugs, painkillers and analgesics — some key medicines used for influenza-like illnesses — have remained mostly unchanged in last three months (January to March), partly explained by the lockdown but also indicating no unusual rise in flu-type infections that might point to a wider and undetected spread of Covid-19. Sales of most medicines, including this set of
Read more

10YearsForSimha: Reasons behind film’s success

By Sumit Blogs -
Image
By Times of India – 10YearsForSimha: Reasons behind film’s success TIMESOFINDIA.COM | Last updated on – Apr 30, 2020, 06:00 ISTclose01/6Take a look at the reasons behind the film’s successDirected by Boyapati Srinu, the 2010 film Simha was a game-changer among Tollywood films that was lauded, not only for Nandamuri Balakrishna’s intense performance in the dual role but also the gripping narration of the filmmaker. Balayya and Nayanthara were seen on the big screen for the first time ever in the film. The action drama made a special place in the hearts of the audience because of its simple storytelling, superhit songs and unbeatable chemistry between the lead pair. The movie has completed a decade, but the essence is as fresh as it was back then. As the film clocks 10 years of its release, find out the reasons behind the massive success of the Balakrishna starrer.readmore02/6​Boyapati Srinu’s gripping narrationBefore Simha, Boyapati Srinu had delivered Bhadra (2005) and Tulasi (2007),
Read more

Hrithik-Saif’s Vikram Vedha hits a roadblock

By Sumit Blogs -
Image
The stage was about to be set for Hrithik Roshan and Saif Ali Khan’s ‘Vikram Vedha’ in Mumbai’s Film City. The material had reached. The artisans had been hired. But the lights have now been dimmed. Madhavan and Vijay Sethupathi’s hit movie Vikram Vedha’s Hindi remake will not go on floors by mid-July as per the original plan. The new delta virus of COVID has sent shudders down many spines and many films which were being laid out on an expansive scale have been either held back or shifted their shoots abroad. The first schedule of this Hrithik-Saif movie will now be shot abroad. A source says, “The Mumbai schedule will be done but later.” Adds the source, “It’s a call that was taken yesterday. It wasn’t an easy call to take, no doubt, but the fact that it’s going to be a costly set made the makers take the safer route rather than be sorry later.” When contacted, General Secretary of FWICE (Federation of Western India Cine Employees), Ashok Dubey, confirmed that the makers of ‘V
Read more